Skip to main content

Reversible cerebral vasoconstriction syndrome triggered by ondansetron

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2

References

  1. Ducros A (2012) Reversible cerebral vasoconstriction syndrome. Lancet Neurol 11:906–917. https://doi.org/10.1016/S1474-4422(12)70135-7

    Article  PubMed  Google Scholar 

  2. Rocha E, Topcuoglu M, Silva G, Singhal A (2019) RCVS2 score and diagnostic approach for reversible cerebral vasoconstriction syndrome. Neurology 92:639–647. https://doi.org/10.1212/WNL.0000000000006917

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Laetitia della Faille.

Ethics declarations

Conflict of interest

The authors have no conflicts of interest to disclose.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

della Faille, L., Claesen, E., Cappelle, S. et al. Reversible cerebral vasoconstriction syndrome triggered by ondansetron. Acta Neurol Belg 121, 1061–1063 (2021). https://doi.org/10.1007/s13760-021-01678-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13760-021-01678-2

Keywords

  • Reversible cerebral vasoconstriction syndrome
  • Arteriopathy
  • Magnetic resonance imaging
  • Ondansetron